Watlington C O, Atkins J L, McNeil J S, Grogan W M, Johnson J P
Department of Medicine, Medical College of Virginia/VCU, Richmond 23298.
J Steroid Biochem. 1988 Dec;31(6):947-54. doi: 10.1016/0022-4731(88)90337-8.
This study was performed to determine whether corticosterone (B), the major glucocorticoid of rat, is metabolized to its 6 beta-OH derivative (6 beta-OH-B) and whether this derivatives has any effects on Na+ or K+ transport in rat kidney. Normal and adrenalectomized (adx) rats were injected with [3H]B and urine was collected for 5 h and examined for metabolites of B. Metabolites were collected by solid phase extraction on mu Bondapak C18 cartridges and fractionated by reversed phase high performance liquid chromatography. Fractions coeluting with 6 beta-OH-B were rechromatographed by normal phase thin layer chromatography. Approximately 5% of the radioactivity recovered from the urine of both intact and adx rats cochromatographed with 6 beta-OH-B on the two systems. Mass spectra of this fraction were virtually identical to those of authentic 6 beta-OH-B, demonstrating that rats do metabolize B to its 6 beta-OH derivative. To evaluate the biological activity of this metabolite, adx rats were injected with NaCl and KCl and with varying dosage of either 6 beta-OH-B or reference steroids (aldosterone, B, 6 beta-OH-F). 6 beta-OH-B produced a significant antinatriuresis at all doses. Kaliuresis occurred only at the highest dose and creatinine excretion increased, suggesting increased glomerular filtration from a glucocorticoid effect. Although 6 beta-OH-B may simply be exerting mineralo- and glucocorticoid actions there are two unexplained findings. First, 6 beta-OH-B (10 micrograms/100 g) significantly decreased urinary K excretion with associated antinatriuresis, an effect which has not been seen with Aldo administration. Second, neither a kaliuretic nor antinatriuretic effect of 6 beta-OH-B could be demonstrated in experiments using a method to enhance mineralocorticoid induced K+ excretion (K+ deprivation and NaCl loading only). Yet, the dose used was clearly antinatriuretic in the initial bioassay. It is concluded that the rat is capable of metabolizing B to its 6 beta-OH-B derivative which appears in substantial quantity in the urine. This metabolite produces antinatriuresis in the adrenalectomized rat.
本研究旨在确定大鼠主要的糖皮质激素皮质酮(B)是否会代谢为其6β-羟基衍生物(6β-OH-B),以及该衍生物对大鼠肾脏中的Na⁺或K⁺转运是否有任何影响。给正常大鼠和肾上腺切除(adx)大鼠注射[³H]B,收集5小时尿液并检测B的代谢产物。代谢产物通过μ Bondapak C18柱上的固相萃取收集,并通过反相高效液相色谱进行分离。与6β-OH-B共洗脱的馏分通过正相薄层色谱进行再色谱分析。在两个系统上,从完整大鼠和adx大鼠尿液中回收的放射性约5%与6β-OH-B共色谱。该馏分的质谱与 authentic 6β-OH-B的质谱几乎相同,表明大鼠确实将B代谢为其6β-OH衍生物。为评估该代谢产物的生物活性,给adx大鼠注射NaCl和KCl以及不同剂量的6β-OH-B或参考类固醇(醛固酮、B、6β-OH-F)。6β-OH-B在所有剂量下均产生显著的钠排泄减少。仅在最高剂量时出现钾排泄增加,肌酐排泄增加,提示糖皮质激素作用导致肾小球滤过增加。尽管6β-OH-B可能只是发挥盐皮质激素和糖皮质激素作用,但有两个无法解释的发现。首先,6β-OH-B(10微克/100克)显著降低尿钾排泄并伴有钠排泄减少,醛固酮给药未出现这种效应。其次,在使用增强盐皮质激素诱导的钾排泄方法(仅钾缺乏和NaCl负荷)的实验中,未证明6β-OH-B有促钾排泄或钠排泄减少的作用。然而,在最初的生物测定中所用剂量显然有钠排泄减少作用。结论是大鼠能够将B代谢为其6β-OH-B衍生物,该衍生物大量出现在尿液中。这种代谢产物在肾上腺切除大鼠中产生钠排泄减少作用。